1-4 of 4
Matthias Leisegang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB073: Adoptive transfer of one CD4TCR and one CD8TCR targeting autochthonous neoantigens are essential and sufficient for eradication of naturally heterogeneous solid tumors

Free
Steven Wolf, Vasiliki Anastasopoulou, Kimberley Drousch, Markus Diehl, Boris Engels, Poh Yin Yew, Kazuma Kiyotani, Yusuke Nakamura, Karin Schreiber, Hans Schreiber, Matthias Leisegang
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB073.
https://doi.org/10.1158/1538-7445.AM2024-LB073
Published: 05 April 2024
View articletitled, Abstract LB073: Adoptive transfer of one CD4TCR and one CD8TCR targeting autochthonous neoantigens are essential and sufficient for eradication of naturally heterogeneous solid tumors
Journal Articles

Abstract 3587: TCR-transduced T cells targeting a truncal mutation caused by a nsSNV destroy large solid tumors despite intratumoral genetic heterogeneity

Free
Matthias Leisegang, Karin Schreiber, Steven P. Wolf, Vasiliki Anastosopolou, Kimberley Borutta, PohYin Yew, Kazuma Kiyotani, Yusuke Nakamura, Hans Schreiber
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3587.
https://doi.org/10.1158/1538-7445.AM2018-3587
Published: 01 July 2018
View articletitled, Abstract 3587: TCR-transduced T cells targeting a truncal mutation caused by a nsSNV destroy large solid tumors despite intratumoral genetic heterogeneity
Journal Articles

Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy

Free
Ramona Schlenker, Luis Felipe Olguín-Contreras, Matthias Leisegang, Julia Schnappinger, Anja Disovic, Svenja Rühland, Peter J. Nelson, Heinrich Leonhardt, Hartmann Harz, Susanne Wilde, Dolores J. Schendel, Wolfgang Uckert, Gerald Willimsky, Elfriede Noessner
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (13): 3577–3590.
https://doi.org/10.1158/0008-5472.CAN-16-1922
Published: 02 July 2017
View articletitled, Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
Open the PDF for Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract 625: Eradication of cancer cells by T-cell receptor-engineered T cells targeting neoantigens/oncoantigens

Free
Tatsuo Matsuda, Taigo Kato, Yuji Ikeda, Matthias Leisegang, Sachiko Yoshimura, Tetsuro Hikichi, Makiko Harada, Makda Zewde, Jae-Hyun Park, Hans Schreiber, Kazuma Kiyotani, Yusuke Nakamura
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 625.
https://doi.org/10.1158/1538-7445.AM2017-625
Published: 01 July 2017
View articletitled, Abstract 625: Eradication of cancer cells by T-cell receptor-engineered T cells targeting neoantigens/oncoantigens